October 11, 2022
Via: Medical Device NetworkHealthtech company Phagenesis has received a de novo approval from the US Food and Drug Administration (FDA) for its Phagenyx neurostimulation system. Phagenyx is claimed to be a first-of-its-kind therapy that uses pharyngeal electrical stimulation (PES) for the restoration of […]
September 14, 2022
Via: Medical Device NetworkVenture capital (VC) financing within healthtech has fallen 41.2% compared to the same time last year. The Asia-Pacific region had the largest year-on-year decrease (-64.8%), followed by Europe (-45.8%), and North America (-38.7%). In contrast, funding for the Middle East […]
September 2, 2022
Via: medicaldevice-network.comIn the first half of 2022 the number of deals relating to healthtech decreased significantly by 40% from the same period in 2021. This marks an acceleration in growth from the 53.6% decrease in deals that occurred in H2 2021 […]
July 17, 2024
Copyright © 2024. All rights reserved
